| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance
|
Azémar, Marie-Dominique
|
|
2011
|
29 |
2 |
p. 130-136
7 p.
|
artikel
|
| 2 |
Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
|
Mayes, Janice M.
|
|
2011
|
29 |
2 |
p. 166-170
5 p.
|
artikel
|
| 3 |
CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa
|
Palmeira, Carlos
|
|
2011
|
29 |
2 |
p. 205-211
7 p.
|
artikel
|
| 4 |
Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer
|
Ding, Guo-Fang
|
|
2011
|
29 |
2 |
p. 145-149
5 p.
|
artikel
|
| 5 |
Commentary on “Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: A phase II study”. Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
|
Trump, Donald L.
|
|
2011
|
29 |
2 |
p. 228-
1 p.
|
artikel
|
| 6 |
Commentary on “Participation of older patients with prostate cancer in Medicare eligible trials”. Craig BM, Gilbert SM, Herndon JB, Vogel B, Quinn GP, Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL
|
Hollenbeck, Brent K.
|
|
2011
|
29 |
2 |
p. 226-
1 p.
|
artikel
|
| 7 |
Commentary on “Sipuleucel-T immunotherapy for castration-resistant prostate cancer”. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
|
Trump, Donald L.
|
|
2011
|
29 |
2 |
p. 230-231
2 p.
|
artikel
|
| 8 |
Commentary on “Symptoms of acute post-traumatic stress disorder in prostate cancer patients following radical prostatectomy”. Anastasiou I, Yiannopoulou KG, Mihalakis A, Hatziandonakis N, Constantinides C, Papageorgiou C, Mitropoulos D, Athens Medical School, Athens and Laiko Medical School, Athens, Greece
|
Hollenbeck, Brent K.
|
|
2011
|
29 |
2 |
p. 227-
1 p.
|
artikel
|
| 9 |
Commentary on “Testicular cancer survivorship: Research strategies and recommendations”. Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD, Department of Radiation Oncology, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
|
Hollenbeck, Brent K.
|
|
2011
|
29 |
2 |
p. 225-
1 p.
|
artikel
|
| 10 |
Commentary on “Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer”. Smith MR, Morton RA, Barnette KG, Sieber PR, Malkowicz SB, Rodriguez D, Hancock ML, Steiner MS, Massachusetts General Hospital Cancer Center, Boston, MA
|
Trump, Donald L.
|
|
2011
|
29 |
2 |
p. 230-
1 p.
|
artikel
|
| 11 |
Commentary on “Trends in renal tumor surgery delivery within the United States”. Dulabon LM, Lowrance WT, Russo P, Huang WC, Department of Urology, New York University School of Medicine, New York, NY
|
Hollenbeck, Brent K.
|
|
2011
|
29 |
2 |
p. 225-226
2 p.
|
artikel
|
| 12 |
Commentary on “Urologist density and county-level urologic cancer mortality”. Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR, Department of Urology, University of California-San Francisco, San Francisco, CA
|
Hollenbeck, Brent K.
|
|
2011
|
29 |
2 |
p. 226-227
2 p.
|
artikel
|
| 13 |
Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: Analysis by the number of lymph nodes removed
|
Jeong, In Gab
|
|
2011
|
29 |
2 |
p. 199-204
6 p.
|
artikel
|
| 14 |
Contents
|
|
|
2011
|
29 |
2 |
p. vi-
1 p.
|
artikel
|
| 15 |
Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide Synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis
|
Sanli, Oner
|
|
2011
|
29 |
2 |
p. 183-188
6 p.
|
artikel
|
| 16 |
Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls
|
Fransson, Per
|
|
2011
|
29 |
2 |
p. 137-144
8 p.
|
artikel
|
| 17 |
Editorial Board
|
|
|
2011
|
29 |
2 |
p. iv-
1 p.
|
artikel
|
| 18 |
Female urethral carcinoma: Evidences to origin from Skene's glands
|
Reis, Leonardo Oliveira
|
|
2011
|
29 |
2 |
p. 218-223
6 p.
|
artikel
|
| 19 |
Hormonal and pathologic changes after chemoablation of testes with hypertonic saline solution as a treatment method alternative to orchiectomy in patients with hormone sensitive metastatic prostatic cancer
|
Emir, Levent
|
|
2011
|
29 |
2 |
p. 212-217
6 p.
|
artikel
|
| 20 |
Information for Authors
|
|
|
2011
|
29 |
2 |
p. IBC-
1 p.
|
artikel
|
| 21 |
Masthead
|
|
|
2011
|
29 |
2 |
p. ii-
1 p.
|
artikel
|
| 22 |
Prognostic factors in metastatic prostate cancer
|
Yigitbasi, Orhan
|
|
2011
|
29 |
2 |
p. 162-165
4 p.
|
artikel
|
| 23 |
Prostate cancer: Evidence-based indications for postoperative radiotherapy
|
Azmi, Aini
|
|
2011
|
29 |
2 |
p. 115-116
2 p.
|
artikel
|
| 24 |
Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study
|
Vinci, Serena
|
|
2011
|
29 |
2 |
p. 150-156
7 p.
|
artikel
|
| 25 |
Re: Clinical significance of the positive surgical margin based upon location, grade and stage
|
Trottier, Greg
|
|
2011
|
29 |
2 |
p. 116-117
2 p.
|
artikel
|
| 26 |
Report of the long-term efficacy of two cycles of adjuvant bleomycin/etoposide/cisplatin in patients with stage I testicular nonseminomatous germ-cell tumors (NSGCT): A risk adapted protocol of the Hellenic Cooperative Oncology Group
|
Bamias, Aristotelis
|
|
2011
|
29 |
2 |
p. 189-193
5 p.
|
artikel
|
| 27 |
Reviews of 3 Clinical Trials
|
Trump, Donald L.
|
|
2011
|
29 |
2 |
p. 228-229
2 p.
|
artikel
|
| 28 |
Second opinion pathology in tertiary care of patients with urologic malignancies
|
Wayment, Robert O.
|
|
2011
|
29 |
2 |
p. 194-198
5 p.
|
artikel
|
| 29 |
Survey Section Editorial Board
|
|
|
2011
|
29 |
2 |
p. 224-
1 p.
|
artikel
|
| 30 |
The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer
|
Eisenberg, Michael L.
|
|
2011
|
29 |
2 |
p. 171-176
6 p.
|
artikel
|
| 31 |
The natural history of voiding function after robot-assisted laparoscopic radical prostatectomy
|
Wang, Lushun
|
|
2011
|
29 |
2 |
p. 177-182
6 p.
|
artikel
|
| 32 |
The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer
|
Ellinger, Jörg
|
|
2011
|
29 |
2 |
p. 124-129
6 p.
|
artikel
|
| 33 |
The role of radical cystectomy in patients with clinical T4b bladder cancer
|
Black, Peter C.
|
|
2011
|
29 |
2 |
p. 157-161
5 p.
|
artikel
|
| 34 |
What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public?
|
Vickers, Andrew
|
|
2011
|
29 |
2 |
p. 118-123
6 p.
|
artikel
|
|
Tijdschrift beschrijving